RNS Number : 5628P
Hansard Global plc
29 May 2018

Date:† 29 May 2018

Hansard Global plc ('The Company')

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Persons Closely Associated with them

The Company was notified on 29 May 2018 that Dr Leonard Polonsky CBE transferred 49,946,319 ordinary shares of 50 pence each in the capital of the Company for nil consideration to the Leonard Polonsky Revocable Trust, a US-established trust of which Dr Polonsky CBE is the sole beneficiary and sole trustee. This being the entire holding of Dr Polonsky CBE in the Company.

Dr Polonsky CBE is a director and The Leonard Polonsky Revocable Trust is deemed to be a person closely associated with Dr Polonsky CBE under Article 19 of the EU Market Abuse Regulation 596/2014.

The Company was informed that these transfers, which took place on 29 May 2018, were for estate planning purposes.

There has been no change in the total number of voting rights in the Company directly or indirectly held by Dr Polonsky CBE as a result of this transfer.

The following disclosure is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Leonard Selwyn Polonsky CBE

2

Reason for the notification

a)

Position/status

PDMR - Director

b)

Initial notification /Amendment†

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name††

Hansard Global plc

b)

LEI††

213800ZJ9F2EA3Q24K05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code†

Hansard Global plc - Ordinary 50p shares

HSD - ISIN IM00B1H1XF89

b)

Nature of the transaction††

Transfer of shares from Dr Leonard Selwyn Polonsky (direct interests) to Dr Leonard Selwyn Polonsky - LPRT (Leonard Polonsky Revocable Trust)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£ nil

49,946,319

d)

Aggregated information

- Aggregated volume

- Price



n/a (single transaction)

e)

Date of the transaction

2018-05-29

f)

Place of the transaction

Transfer of shares occurred outside a trading venue

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Dr Leonard Selwyn Polonsky - LPRT (Leonard Polonsky Revocable Trust)

2

Reason for the notification

a)

Position/status

Person Closely Associated with Dr Leonard Selwyn Polonsky, a Director of Hansard Global plc

b)

Initial notification /Amendment†

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name††

Hansard Global plc

b)

LEI††

213800ZJ9F2EA3Q24K05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code†

Hansard Global plc - Ordinary 50p shares

HSD - ISIN IM00B1H1XF89

b)

Nature of the transaction††

Transfer of shares from Dr Leonard Selwyn Polonsky (direct interests) to Dr Leonard Selwyn Polonsky - LPRT (Leonard Polonsky Revocable Trust)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£ nil

49,946,319

††

d)

Aggregated information

- Aggregated volume

- Price



n/a (single transaction)

e)

Date of the transaction

2018-05-29

f)

Place of the transaction

Transfer shares occurred outside a trading venue

Name of authorised official of issuer responsible for making notification:

Grace Hibbert - Assistant Company Secretary

Date of notification: 29 May 2018


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHLLFSFELIAFIT